DERL1 | Derlin 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
DERL2 | Derlin 2 | Predicted membrane proteins
| | | | | Expressed in all |
DERL3 | Derlin 3 | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DNAJC13 | DnaJ (Hsp40) homolog, subfamily C, member 13 | Predicted membrane proteins
| | | | | Expressed in all |
DNAJC14 | DnaJ (Hsp40) homolog, subfamily C, member 14 | Predicted membrane proteins
| | | | | Expressed in all |
DOLPP1 | Dolichyldiphosphatase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
DPY19L1 | Dpy-19-like 1 (C. elegans) | Predicted membrane proteins
| | | | | Expressed in all |
DPY19L3 | Dpy-19-like 3 (C. elegans) | Predicted membrane proteins
| | | | | Mixed |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EBPL | Emopamil binding protein-like | Predicted membrane proteins
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
EMP1 | Epithelial membrane protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
ERMP1 | Endoplasmic reticulum metallopeptidase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
FA2H | Fatty acid 2-hydroxylase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FADS1 | Fatty acid desaturase 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
FADS3 | Fatty acid desaturase 3 | Predicted membrane proteins
| | | | | Expressed in all |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
FAM134A | Family with sequence similarity 134, member A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAM189A1 | Family with sequence similarity 189, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM189B | Family with sequence similarity 189, member B | Predicted membrane proteins
| | | | | Expressed in all |
FAM26D | Family with sequence similarity 26, member D | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
FAM26E | Family with sequence similarity 26, member E | Predicted membrane proteins
| | | | | Mixed |
FAM26F | Family with sequence similarity 26, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
FAXDC2 | Fatty acid hydroxylase domain containing 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FZD6 | Frizzled family receptor 6 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRA2 | Gamma-aminobutyric acid (GABA) A receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GABRA3 | Gamma-aminobutyric acid (GABA) A receptor, alpha 3 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GABRA6 | Gamma-aminobutyric acid (GABA) A receptor, alpha 6 | FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRE | Gamma-aminobutyric acid (GABA) A receptor, epsilon | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
GABRG1 | Gamma-aminobutyric acid (GABA) A receptor, gamma 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GABRG3 | Gamma-aminobutyric acid (GABA) A receptor, gamma 3 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GABRR2 | Gamma-aminobutyric acid (GABA) A receptor, rho 2 | FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GJA10 | Gap junction protein, alpha 10, 62kDa | Predicted membrane proteins
| | | | | Not detected |
GJA4 | Gap junction protein, alpha 4, 37kDa | Predicted membrane proteins Transporters
| | | | | Mixed |
GJA5 | Gap junction protein, alpha 5, 40kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJB2 | Gap junction protein, beta 2, 26kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GJB5 | Gap junction protein, beta 5, 31.1kDa | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |